press-releases

Jul 27, 2022, 16:15 ET CUPERTINO, Calif., July 27, 2022 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX) today announced that it will report its second quarter 2022 financial results and host a conference call after the market close on Thursday, August 4, 2022. Thursday, August 4 @ 4:30pm Eastern Time / 1:30pm Pacific Time Toll Free: 1-877-869-3847 […]

Jul 05, 2022, 08:30 ET CUPERTINO, Calif., July 5, 2022 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company focused on epigenetic regulation to develop treatments for acute organ injury and chronic liver diseases, today announced the appointment of Timothy M. Papp as its Chief Financial Officer. In this new role, Mr. Papp will direct and oversee all financial